Japan, Oct. 15 -- TARSUS PHARMACEUTICALS INC has got intellectual property rights for 'ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS.' Other related details are as follows:
Application Number: JP,2024-006895
Category (FI): A61K9/08,A61K9/10,A61K9/06,A61K31/155,A61P33/10,A61P27/02,A61K47/38,A61K31/422,A61K47/10,A61K47/44,A61K47/18,A61K47/32,A61K31/42,A61K47/26
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Jan. 19, 2024
Publication Date: March 19, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
